COVID-19 Updates
Multimedia
Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics?
News
Amid hydroxychloroquine hopes, lupus patients face shortages
Pharmacists are reporting depleted stocks of the drug, leaving many of the roughly...
News
SECURE-IBD registry traces COVID-19 in patients with Crohn’s, colitis
Gastroenterologists and other clinicians caring for patients with IBD are being encouraged to report outcomes for pediatric and adult patients...
News
Should patients with COVID-19 avoid ibuprofen or RAAS antagonists?
News from the FDA/CDC
Flu now riding on COVID-19’s coattails
CDC suggests that current climate of increased “healthcare seeking behavior” may be affecting data on influenza.
Commentary
Preventable diseases could gain a foothold because of COVID-19
Measles and influenza are two deadly infectious diseases for which there are vaccines.
News
New ASAM guideline released amid COVID-19 concerns
During the COVID-19 pandemic, “it is especially important” for clinicians to ensure that individuals with OUD continue to receive evidence-based...
News
DIY masks: Worth the risk? Researchers are conflicted
Some health care workers are making their own personal protective equipment.
News
COVID-19 prompts ‘lifesaving’ policy change for opioid addiction
Patients in some opioid treatment programs will be allowed to take home their medication.
News
Feds tout drug candidates to treat COVID-19
Food and Drug Administration officials and President Trump highlighted hydroxychloroquine and remdesivir.